Advanced 3D imaging technology for observing nanoscale biological structures
Three-Dimensional (3D) Acoustofluidic Scanning Nanoscope with Super Resolution and Large Field of View
This study is exploring a new 3D imaging tool that helps scientists see tiny biological structures more clearly, which could lead to better ways to diagnose and treat diseases that affect you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Dayton NIH-funded |
| Lab location | 1 site (Dayton, United States) |
| Project ID | NIH-10886747 on NIH RePORTER |
What this research studies
This research focuses on developing a new type of 3D imaging technology called an acoustofluidic scanning nanoscope, which allows scientists to visualize biological structures at the nanoscale with unprecedented detail. By combining super-resolution imaging with a large field of view, this technology aims to overcome the limitations of traditional imaging methods. Patients may benefit from insights gained into cellular processes that could lead to improved diagnostics and treatments for various diseases. The research involves validating the imaging capabilities through rigorous testing and comparison with existing techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve cellular abnormalities or diseases where detailed cellular imaging could provide critical insights.
Not a fit: Patients with conditions that do not involve cellular imaging or those who are not undergoing treatment that requires detailed biological analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding cellular functions and disease mechanisms, ultimately improving patient care.
How similar studies have performed: Previous advancements in super-resolution imaging technologies have shown significant success, indicating a strong potential for this novel approach.
Where this research is happening
Dayton, United States
- University of Dayton — Dayton, United States (Active)
Researchers
- Principal investigator: Agha, Imad — University of Dayton
- Study coordinator: Agha, Imad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.